Hydralazine Hydrochloride Tablet
Product Images NDC 50111-327

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 50111-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 1

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 2

Hydrochloride Tablets USP containing 10mg of HydrALAZINE are available in a bottle of 100 tablets. The tablets are manufactured by TEVA CZECH INDUSTRIES in Opava-Komarov, Czech Republic. The NDC number is 50111-398-01 and the product should be stored at USP controlled room temperature. The label warns to keep it out of the reach of children. The revision A 2/2016 is also mentioned.*

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 3

This is a medication label for a 25mg Hydralochloride tablet. The package insert has prescribing information, and it is important to store the medication at room temperature. The manufacturer is located in the Czech Republic. The label also includes a warning to keep the medication out of the reach of children.*

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 4

These are Hydrochloride Tablets USP containing 50 mg of Hydralazine Hydrachloride, USP. The package includes 100 tablets and is marked with NDC 50111-328-01. The package insert should be referred to for further information. The medication should be kept out of reach of children. The manufacturer is TEVA CZECH INDUSTRIES and the product is made in Czech Republic. This was last revised in February 2016.*

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 5

This is a description of Hydralazine Hydrochloride Tablets USP, a medication approved by the FDA with a national drug code of 50111-397-01. Each of its 100 tablets contains 100 mg of hydralazine hydrochloride, USP. It is manufactured in the Czech Republic by Industries s.r.o and distributed in the United States by Teva Pharmaceuticals USA, Inc. Further dosage instructions can be found in the package insert provided with the medication, and it should be kept out of the reach of children. The product was last revised in February 2016.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.